CATALYST trial protocol: a multicentre, open-label, phase II, multiarm trial for an early and accelerated evaluation of the potential treatments for COVID-19 in hospitalised adults. (2021)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1136/bmjopen-2021-050202
PubMed Identifier: 34764169
Publication URI: http://europepmc.org/abstract/MED/34764169
Type: Journal Article/Review
Volume: 11
Parent Publication: BMJ open
Issue: 11
ISSN: 2044-6055